BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17679828)

  • 1. Prehypertension and the cardiometabolic syndrome: is there any value in pharmacologic intervention?
    Ferdinand KC
    J Cardiometab Syndr; 2006; 1(2):146-8. PubMed ID: 17679828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
    Ferdinand KC
    J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of home blood pressure and ambulatory blood pressure monitoring in decisions of when and whom to treat: recommendations for practicing clinicians.
    Ogedegbe G
    J Cardiometab Syndr; 2006; 1(3):222-4. PubMed ID: 17679827
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
    Basile J; Houston M; Ferrario CM
    J Cardiometab Syndr; 2006; 1(5):358-61. PubMed ID: 17679795
    [No Abstract]   [Full Text] [Related]  

  • 5. Prehypertension and the cardiometabolic syndrome: pathological and clinical consequences.
    Duprez D; Toleuova A
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1725-33. PubMed ID: 24215200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hypertension in children and adolescents with the metabolic syndrome.
    Puri M; Flynn JT
    J Cardiometab Syndr; 2006; 1(4):259-68. PubMed ID: 17679805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some thoughts about recent hypertension trials.
    Conti CR
    Clin Cardiol; 2007 Jun; 30(6):268-70. PubMed ID: 17551957
    [No Abstract]   [Full Text] [Related]  

  • 8. Early detection and management of the high-risk patient with elevated blood pressure.
    Sierra C; de la Sierra A
    Vasc Health Risk Manag; 2008; 4(2):289-96. PubMed ID: 18561504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension and the cardiometabolic syndrome--is it the blood pressure lowering or the blood pressure medication that is important?
    Ferdinand KC
    J Cardiometab Syndr; 2006; 1(1):72-3. PubMed ID: 17675893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it time to target prehypertension.
    Whaley-Connell A; Sowers JR
    Cardiovasc Ther; 2010 Dec; 28(6):337-8. PubMed ID: 21050419
    [No Abstract]   [Full Text] [Related]  

  • 11. Perspectives on prehypertension.
    Nesbitt SD
    J Cardiometab Syndr; 2006; 1(5):364-5. PubMed ID: 17679784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current role of beta-blockers in the treatment of hypertension.
    Aronow WS
    Expert Opin Pharmacother; 2010 Nov; 11(16):2599-607. PubMed ID: 20426702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prehypertension: the rationale for early drug therapy.
    Fuchs FD
    Cardiovasc Ther; 2010 Dec; 28(6):339-43. PubMed ID: 20553286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are guidelines effectively guiding antihypertensive therapy?
    Vasan RS; Kannel WB
    Am J Cardiol; 2007 Jul; 100(1):143-4. PubMed ID: 17599457
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood pressure and antihypertensive therapy according to the global cardiovascular risk level in Italy: the CHECK Study.
    Filippi A; Casula M; Tragni E; Brignoli O; Cricelli C; Poli A; Catapano AL;
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):562-8. PubMed ID: 20308908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global Risk Assessment to Guide Blood Pressure Management in Cardiovascular Disease Prevention.
    Karmali KN; Lloyd-Jones DM
    Hypertension; 2017 Mar; 69(3):e2-e9. PubMed ID: 28115516
    [No Abstract]   [Full Text] [Related]  

  • 17. Annual influenza immunization: as important as control of blood pressure and cholesterol as secondary prevention for cardiovascular disease.
    Grajewski J; Slusar M; Hayney MS
    J Am Pharm Assoc (2003); 2007; 47(5):662-3. PubMed ID: 17848356
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment options for prehypertension.
    Nesbitt SD
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):250-5. PubMed ID: 17420669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic treatment for prehypertension: to treat or not to treat?
    Martin JF; Martin LN; Cipullo JP
    Recent Pat Cardiovasc Drug Discov; 2009 Jun; 4(2):133-41. PubMed ID: 19519555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How early should blood pressure control be achieved for optimal cardiovascular outcomes?
    Weir MR; Zappe D; Orloski LA; Sowers JR
    J Hum Hypertens; 2011 Apr; 25(4):211-7. PubMed ID: 20596060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.